News
Subscriptions received in separate tranche of previously announced directed share issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Board member resigns at his request
OSLO, NORWAY – November 2, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the…
Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers
GA-map new product Discovery launch
New Luminex whitepaper describes how the GA-map® Dysbiosis Test utilizes xMAP® technology for microbiome profiling
Bacteria residing in the gastrointestinal tract modulate many bodily functions from nutrient metabolism to immune system regulation. This whitepaper describes…
Genetic Analysis: Development project initiated for a new companion diagnostic test
OSLO, NORWAY – 12 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company…
Chinese pharma and medtech visit Genetic Analysis
Genetic Analysis AS had the pleasure of hosting a morning presentation to Chinese Pharma and Medtech leaders on our Oslo…
Stay updated and subscribe to GA investor newsletters, financial reports and press releases
New subscription web page We are thrilled to announce the launch of our new subscription webpage specifically designed for investor…
Half-year report January–June 2023
OSLO, NORWAY, August 30, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the half-year report for the…
Genetic Analysis AS ramps up its market presence for the GA-map® microbiome testing in the US
OSLO, NORWAY – August 25, 2023: Microbiome diagnostics specialist, Genetic Analysis AS (“GA”) has through its distributor Eagle Biosciences Inc,…
New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2
OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific…
Genetic Analysis receives patent approval in South Africa
OSLO, NORWAY – June 29, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company…
Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map® technology in the Balkan region
OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 26 May 2023: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…